Ranbaxy recalls nearly 30,000 packs of allergy-relief drug

Whatsapp News

MUMBAI – drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United in February, after finding defects in the packaging, the .S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the ’s only facility making generics for the United .

All other Ranbaxy plants, based in India, have been banned from exporting generics the United after the FDA found manufacturing glitches the agency believed could compromise the of medicines.

Rival drugmaker Sun Pharmaceutical Industries Ltd agreed buy Ranbaxy last month in a $3.2 deal, betting can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure the recalled cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment. (Reuters)